Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Strontium

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    32 result(s) found for: Strontium. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2005-001587-31 Sponsor Protocol Number: A001-2PX Start Date*: 2005-06-07
    Sponsor Name:SantoSolve AS
    Full Title:
    Medical condition: Patients with fibromyalgia diagnosed according to ACR classification (1990) and with chronic pain at defined symmetrical body areas.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004316-73 Sponsor Protocol Number: 3189 Start Date*: 2006-08-23
    Sponsor Name:Royal Liverpool University hospital
    Full Title: The effects of growth hormone, strontium ranelate and phosphate on PTH circadian rhythm, PTH target organ sensitivity, bone turnover markers, phospho-calcium metabolism and bone mineral density. A ...
    Medical condition: Osteoporosis and Reduced Bone mineral density (T scores< -1.0 on DEXA scan), Adult growth hormone deficiency ( GH levels,9mU/l on Insulin stress test) with reduced BMD (T scores< -1.0 on DEXA scan)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2010-020215-36 Sponsor Protocol Number: CL3-12911-037 Start Date*: 2011-05-03
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: A prospective, controlled, double blind, international study to assess the effects of strontium ranelate vs. placebo on the reduction of periprosthetic bone loss in patients with total hip arthropl...
    Medical condition: Reduction of periprosthetic bone loss in patients with total hip arthoplasty for coxarthrosis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10022117 - Injury, poisoning and procedural complications 10052306 Periprosthetic osteolysis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) ES (Completed) IT (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003615-40 Sponsor Protocol Number: NBS-C03-OP Start Date*: 2006-10-10
    Sponsor Name:Osteologix A/S
    Full Title: A dose-response study with stronitum malonate in postmenopausal women. 12 week, multinational, double-blind, randomised, 5 arms, parallel group placebo controlled, open label active controlled, ph...
    Medical condition: postmenopausal osteoporosis
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed) GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-002370-23 Sponsor Protocol Number: CL2-12911-039 Start Date*: 2011-11-30
    Sponsor Name:INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
    Full Title: A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelli...
    Medical condition: Dental implantation in osteoporotic patients or in patients at risk of osteoporotic fracture.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10042613 Surgical and medical procedures SOC
    14.1 10042613 - Surgical and medical procedures 10064143 Dental implantation PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended) DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-006086-16 Sponsor Protocol Number: CL3-12911-032 Start Date*: 2007-12-06
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: The efficacy and safety of 2g strontium ranelate in the treatment of male osteoporosis. A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of...
    Medical condition: male osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031282 Osteoporosis PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: HU (Completed) BE (Completed) NL (Completed) FR (Completed) SE (Completed) IE (Completed) IT (Completed) ES (Completed) DE (Completed) PL (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-000715-29 Sponsor Protocol Number: SR-SJI/AM Start Date*: 2007-04-16
    Sponsor Name:University Hospitals of Leicester - Research & Development
    Full Title: Serum and urinary strontium levels and possible interference with measurement of other minerals in subjects taking Strontium ranelate (Protelos) for osteoporosis.
    Medical condition: Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    13.1 10028395 - Musculoskeletal and connective tissue disorders 10031282 Osteoporosis PT
    13.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-014271-41 Sponsor Protocol Number: CL3-12911-035 Start Date*: 2010-03-16
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: A multicenter, prospective, randomized, double-blind, placebo-controlled, international study to assess the effects of 2g per day of strontium ranelate versus placebo on the time to fracture healin...
    Medical condition: Osteoporotic men and post menopausal osteoporotic women with a fracture of the distal radius
    Disease: Version SOC Term Classification Code Term Level
    14.0 10028395 - Musculoskeletal and connective tissue disorders 10031288 Osteoporosis with fracture LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) DE (Completed) IT (Completed) HU (Completed) GB (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005581-39 Sponsor Protocol Number: CL3-12911-025 Start Date*: 2007-04-02
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: A double-blind, multicenter, international randomised study to assess the effects of 6 months or 12 months administration of 2g per day of strontium ranelate versus alendronate 70mg per week on bo...
    Medical condition: Treatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fractures
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed) FR (Completed) HU (Completed) NL (Completed) CZ (Completed) IT (Completed) DK (Completed) EE (Completed) GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-003138-16 Sponsor Protocol Number: Ed001 Start Date*: 2005-08-26
    Sponsor Name:R+ D department, Hull and East Yorkshire NHS Hospital Trust
    Full Title: A clinical observational study to assess the effectiveness of Strontium Ranelate on bone protection in osteoporotic patients pre-treated with bisphosphonates.
    Medical condition: Postmenopausal Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10031285 Osteoporosis postmenopausal LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-000515-95 Sponsor Protocol Number: B3D-EW-GHCX Start Date*: 2005-06-16
    Sponsor Name:Eli Lilly and Company Limited
    Full Title: Differential Effects of Teriparatide and Strontium Ranelate on Bone Remodeling and Formation in Postmenopausal Women with Osteoporosis: A Histomorphometric Study
    Medical condition: Osteoporosis
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: CZ (Completed) ES (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-002494-75 Sponsor Protocol Number: CL3-12911-018 Start Date*: 2006-04-26
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, int...
    Medical condition: Osteoarthritis
    Disease: Version SOC Term Classification Code Term Level
    7.0 10031161 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed) BE (Completed) GB (Completed) ES (Completed) IT (Completed) DK (Completed) PT (Completed) LT (Completed) EE (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2011-000708-17 Sponsor Protocol Number: CL3-12911-038 Start Date*: 2011-08-30
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: A 24 months, prospective, randomized, double-blind study to assess the effect of daily oral administration of 2 g of strontium ranelate versus placebo on bone mineral density in postmenopausal oste...
    Medical condition: Postmenopausal osteoporotic women
    Disease: Version SOC Term Classification Code Term Level
    16.0 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed) AT (Prematurely Ended) BE (Completed) HU (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-001509-11 Sponsor Protocol Number: CL3-12911-030 Start Date*: 2007-10-31
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with p...
    Medical condition: Post-menopausal osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Completed) IT (Completed) DE (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2006-002732-22 Sponsor Protocol Number: CL3-12911-019 Start Date*: 2006-09-08
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2g per day of strontium ranelate versus alendronate 70mg per week in women with pos...
    Medical condition: Treatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fractures
    Disease: Version SOC Term Classification Code Term Level
    8.1 10031290 Osteoporotic fracture PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-013935-39 Sponsor Protocol Number: CL3-06911-002 Start Date*: 2009-12-28
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: The efficacy and safety of a daily oral administration of S06911 (strontium ranelate 2g/vitamin D3 1000 IU fixed combination) on vitamin D insufficiency in the treatment of osteoporotic postmenopau...
    Medical condition: Osteoporotic men and postmenauposal women
    Disease: Version SOC Term Classification Code Term Level
    12.0 10031283 Osteoporosis fracture LLT
    12.0 10031285 Osteoporosis postmenopausal LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed) ES (Completed) FR (Completed) BE (Completed) GB (Completed) CZ (Completed) DE (Completed) DK (Prematurely Ended) AT (Completed) HU (Completed) PL (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2008-008593-31 Sponsor Protocol Number: 2PX-OA-03 Start Date*: 2009-04-03
    Sponsor Name:SantoSolve A/S
    Full Title: A 26 week placebo-controlled, randomised, double-blind, parallel group study of the efficacy and safety of 2PX (topical strontium chloride hexahydrate) in patients with pain due to osteoarthritis o...
    Medical condition: pain associated with osteoarthritis of the knee
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031161 Osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed) GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-017039-16 Sponsor Protocol Number: CL3-12911-036 Start Date*: 2010-05-05
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: Effect of strontium ranelate (2g per day) in the management of long bone fractures with delayed-union or non union: an international open label study
    Medical condition: Delayed and non-united fractures
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10017088 Fracture nonunion PT
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10017081 Fracture delayed union PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) HU (Completed) FR (Completed) IT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-004717-17 Sponsor Protocol Number: CL3-12911-016 Start Date*: 2007-03-26
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: The efficacy and safety of 2g strontium ranelate in the treatment of osteoporosis in men. A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration...
    Medical condition: Osteoporosis in men
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031282 Osteoporosis PT
    Population Age: Elderly Gender: Male
    Trial protocol: EE (Prematurely Ended) DK (Prematurely Ended) CZ (Prematurely Ended) LT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-002693-66 Sponsor Protocol Number: 0822-018 Start Date*: 2007-11-13
    Sponsor Name:MERCK SHARP & DOHME CORP.
    Full Title: A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of MK-0822 to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D an...
    Medical condition: Postmenopausal Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Elderly Gender: Female
    Trial protocol: LT (Completed) DK (Completed) CZ (Prematurely Ended) PL (Prematurely Ended) GB (Prematurely Ended) DE (Completed) FR (Prematurely Ended) BE (Prematurely Ended) LV (Completed) EE (Completed) IT (Completed) ES (Completed) BG (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 21:40:50 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA